PSORIATIC ARTHRITIS

Open Access
Potential Impact of Sex and BMI on Response to Therapy in Psoriatic Arthritis: Post Hoc Analysis of Results From the SEAM-PsA Trial
Philip J. Mease, Dafna D. Gladman, Joseph F. Merola, Atul Deodhar, Alexis Ogdie, David H. Collier, Lyrica Liu and Arthur Kavanaugh

The Journal of Rheumatology August 1 2022, 49 (8) 885-893; DOI: https://doi.org/10.3899/jrheum.211037
Open Access
Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study
Tien Nguyen, Melvin Churchill, Robert Levin, Guillermo Valenzuela, Joseph F. Merola, Alexis Ogdie, Ana-Maria Orbai, Jose U. Scher, Arthur Kavanaugh, Farid Kianifard, Chauncy Rollins, Renato Calheiros and Olivier Chambenoit

The Journal of Rheumatology August 1 2022, 49 (8) 894-902; DOI: https://doi.org/10.3899/jrheum.210912
Open Access
Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis
Philip J. Mease, Arthur Kavanaugh, Alexis Ogdie, Alvin F. Wells, Martin Bergman, Dafna D. Gladman, Sven Richter, Lichen Teng, Shauna Jardon and Josef S. Smolen

The Journal of Rheumatology July 1 2022, 49 (7) 694-699; DOI: https://doi.org/10.3899/jrheum.210906
Open Access
Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Philip J. Mease, Taylor Blachley, Blessing Dube, Robert R. McLean, Nina Kim, Peter Hur and Alexis Ogdie

The Journal of Rheumatology July 1 2022, 49 (7) 700-706; DOI: https://doi.org/10.3899/jrheum.211033
You have access
Prologue: 2021 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
Kristina Callis Duffin, Dafna D. Gladman, Niti Goel, Alice B. Gottlieb, Oliver FitzGerald and Lynne V. McFarland

The Journal of Rheumatology June 1 2022, 49 (6 Suppl 1) 1-3; DOI: https://doi.org/10.3899/jrheum.211317
You have access
COVID-19 Update for the GRAPPA 2021 Annual Meeting: Focus on COVID-19 Vaccination
Philip J. Mease, Kevin Winthrop, Wendy Olsder and Jeffrey R. Curtis

The Journal of Rheumatology June 1 2022, 49 (6 Suppl 1) 10-12; DOI: https://doi.org/10.3899/jrheum.211319
You have access
Basic Science Session 1. Biomarkers for Psoriatic Arthritis Treatment Response and Joint Damage Progression: An Update on 2 Industry-GRAPPA Projects
James C. Waddington, Orla Coleman, Philip J. Mease, Vinod Chandran, Denis O’Sullivan, Oliver FitzGerald and Stephen R. Pennington

The Journal of Rheumatology June 1 2022, 49 (6 Suppl 1) 13-15; DOI: https://doi.org/10.3899/jrheum.211320
You have access
Basic Science Session 2. Recent Advances in Our Understanding of Psoriatic Arthritis Pathogenesis
Erik Lubberts, Jose U. Scher and Oliver FitzGerald

The Journal of Rheumatology June 1 2022, 49 (6 Suppl 1) 16-19; DOI: https://doi.org/10.3899/jrheum.211321
You have access
Plain Radiographic Instruments for Structural Damage in Peripheral Joints in Psoriatic Arthritis: A Report From the GRAPPA-OMERACT Working Group
Anna Antony, Richard Holland, Ashish J. Mathew, Maria-Antoinetta D’Agostino, Walter P. Maksymowych, Philip J. Mease, Niti Goel, Alexis Ogdie, Laura C. Coates, Vibeke Strand, Robin Christensen, Dafna D. Gladman, Ana-Maria Orbai, Ying Ying Leung and William Tillett

The Journal of Rheumatology June 1 2022, 49 (6 Suppl 1) 20-25; DOI: https://doi.org/10.3899/jrheum.211322
You have access
Clinical Controversies in Psoriatic Disease: The Use of IL-17i/IL-23i Versus TNFi as First-line Advanced Therapy in Psoriatic Arthritis
Deepak R. Jadon, Arthur Kavanaugh and Ying Ying Leung

The Journal of Rheumatology June 1 2022, 49 (6 Suppl 1) 26-31; DOI: https://doi.org/10.3899/jrheum.211325

Main menu

User menu

Search

PSORIATIC ARTHRITIS

Pages

Content

Resources

Subscribers

More